发行股份及可转换公司债券购买资产并募集配套资金暨关联交易方案的议案》等 与本次交易相关的议案，具体内容详见公司于 2025 年 5 月 13 日刊登在上海证券 交易所网站（www.sse.com.cn）和指定信息披露媒体的《北京阳光诺和药物研究 股份有限公司发行股份及可转换公司债券购买资产并募集配套资金暨关联交易 预案》及相关公告。 根据《上市公司重大资产重组管理办法》 证券代码：688621 证券简称：阳光诺和 公告编号：2025-039 北京阳光诺和药物研究股份有限公司 关于暂不召开股东会审议本次发行股份 及可转换公司债券并募集配套资金 暨关联交易事项的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 北京阳光诺和药物研究股份有限公司（以下简称"公司"或"上市公司"） 拟通过发行股份及可转换公司债券方式购买江苏朗研生命科技控股有限公司（以 下简称"朗研生命"）100%股权，并向不超过 35 名特定投资者发行股份募集配 套资金（以下简称"本次交易"）。 《上市公司证券发行注册管理办法》 《上市公司监管指引第 9 号— ...

证券代码：688621 证券简称：阳光诺和 公告编号：2025-044 北京阳光诺和药物研究股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 北京阳光诺和药物研究股份有限公司（以下简称"公司"或"上市公司"） 于2025年5月12日召开第二届董事会第十九次会议。本次会议通知于2025年5月8 日以直接送达、传真与邮件方式发出，会议由董事长利虔先生召集和主持，会议 应出席董事9名，实际出席董事9名，会议的召集和召开符合《中华人民共和国公 司法》（以下简称"《公司法》"）及《北京阳光诺和药物研究股份有限公司章程》 （以下简称"《公司章程》"）等法律、行政法规、部门规章、规范性文件的规定。 二、董事会会议审议情况 经与会董事认真审议，一致通过如下决议： 具体内容详见公司于同日在上海证券交易所网站（http://www.sse.com.cn） 披露的《北京阳光诺和药物研究股份有限公司2025年限制性股票激励计划（草 案）》 《北京阳光诺和药物研究股份有限公司2025年限制性股票激励计划（草案）》 ...

Group 1: Apple - Apple is reportedly considering a price increase for the upcoming iPhone product series in the fall [3] - There are rumors of a price drop of over 1000 yuan for the new iPhone, with some retailers indicating a recent price reduction of 600 yuan for the iPhone 16 Pro (512GB) [2] Group 2: ByteDance - Reports of ByteDance veteran Chen Lin leaving to start a new venture have been denied by insiders, stating the information is false [4] Group 3: Xiaomi - Xiaomi explained the disappearance of the "LEICA" watermark on its camera models, stating it is in compliance with Leica's updated visual standards [5] Group 4: Huawei - Huawei has signed a comprehensive cooperation agreement with UBTECH Robotics, focusing on innovation in embodied intelligence and humanoid robotics [5] Group 5: Tencent - Tencent's WeChat and QQ platforms have launched nationwide earthquake warning features, enhancing disaster preparedness capabilities [7] Group 6: Meituan - Meituan has made a significant investment in the company Self-Variable Robot, which has completed a multi-hundred million yuan Series A financing round [8] Group 7: BYD - BYD has entered the Romanian market, planning to open over 30 sales points by the end of 2025, with initial products including several electric vehicle models [11] Group 8: Shanghai Pharmaceuticals - Shanghai Pharmaceuticals has received approval for the production of the chemical raw material drug Vilapig, with no other manufacturers currently producing it in China [16] Group 9: Ningde Times - Ningde Times is set to launch the largest IPO in Hong Kong this year, aiming to raise between 4 billion to 5 billion USD, with plans to issue 118 million shares [19] Group 10: CIFI Holdings - CIFI Holdings' CFO emphasized the importance of aligning domestic and international restructuring plans, suggesting that creditors consider debt-to-equity swaps [21] Group 11: Guizhou Moutai - Guizhou Moutai's management addressed inquiries about using celebrity endorsements for marketing, indicating no current plans for such strategies [23] Group 12: Zhangyue Technology - Zhangyue Technology reported that its short drama business has become the largest segment of its operations, with significant revenue growth in the first quarter [24]

证券代码：603127 证券简称：昭衍新药 公告编号：2025-020 根据公司《2021年A股限制性股票激励计划（草案）》和《股权激励计划实 施考核管理办法》等相关规定，由于21名激励对象因个人原因离职或个人业绩考 核结果不达标，已不符合公司股权激励计划中有关激励对象的规定，董事会审议 决定回购注销限制性股票3.1108万股。 公司按照规定回购注销2019年限制性股票0.3293万股，回购价格8.21元/股； 回购注销2021年限制性股票3.1108万股，回购价格59.72/股。综上，公司合计回 购注销股票3.4401万股。 公司于2025年1月23日召开的2025年第一次临时股东大会审议通过了《关于 公司变更注册资本的议案》，根据决议，上述回购注销完成后，公司总股本由 公司本次回购注销部分股权激励限制性股票将导致注册资本减少，根据《中 华人民共和国公司法》等相关法律、法规的规定，公司特此通知债权人，债权人 自本公告之日起四十五日内，有权要求公司清偿债务或者提供相应的担保。债权 人未在规定期限内行使上述权利的，本次回购注销将按法定程序继续实施。公司 债权人如要求公司清偿债务或提供相应担保的，应根据《中华人民 ...

Group 1: Automotive Sector - Chinese electric vehicle manufacturers achieved a wholesale penetration rate of 51.7% in April, up 11 percentage points year-on-year. The wholesale sales of new energy passenger vehicles reached 1.133 million units, a year-on-year increase of 40.2% and a month-on-month increase of 0.3%. Cumulative wholesale from January to April reached 3.981 million units, growing by 42.1% [1] - Retail sales of new energy passenger vehicles in April were 905,000 units, a year-on-year increase of 33.9% but a month-on-month decrease of 8.7%. Cumulative retail from January to April reached 3.324 million units, growing by 35.7% [1] - Exports of new energy passenger vehicles in April totaled 189,000 units, a year-on-year increase of 44.2% and a month-on-month increase of 31.6%. Cumulative exports from January to April reached 590,000 units, growing by 26.7% [1] Group 2: Automotive Parts Sector - Chinese auto parts stocks rose, with companies like Minth Group and Delta Electronics seeing increases of 4.07% and 3.58% respectively. The competitive advantage of Chinese parts manufacturers in the U.S. remains strong according to Guotai Junan [1] Group 3: Beverage Sector - Beer stocks saw a general increase, with China Resources Beer rising over 3% and Budweiser APAC rising over 2%. Dongwu Securities reported a recovery in the beer sector for Q1 2025 [1] Group 4: Technology Sector - KEEP's stock rose over 10% as the company accelerates AI integration, potentially breaking through user scale and commercialization ceilings [1] - Apple-related stocks performed well, with Sunny Optical Technology rising over 10% and AAC Technologies rising over 8%. Apple announced price reductions for iPhone 16 Pro and Pro Max in preparation for the 618 shopping festival [2] Group 5: Pharmaceutical Sector - Pharmaceutical stocks faced significant declines following U.S. President Trump's announcement of an executive order to align U.S. prescription drug prices with those of the lowest-priced countries, potentially causing prices to drop by 30% to 80% [2] - Faraday Pharmaceuticals saw an increase of over 8%, with a month-to-date rise exceeding 35% due to multiple drug development and clinical promotion updates [2] Group 6: Gaming Sector - Gaming stocks rose as institutions reported that the Golden Week gambling revenue significantly exceeded expectations, with companies like Melco International Development and Galaxy Entertainment seeing increases of over 6% and 4% respectively [2] Group 7: U.S. Market Highlights - Crowdstrike's stock fell 4.21% due to an investigation by the U.S. Department of Justice and SEC regarding a $32 million transaction with Carahsoft Technology Corp [4] - Lyft's stock surged 28.08% after reporting Q1 revenue growth of 14% to $1.45 billion, with a net profit of $2.6 million [4] - The Trade Desk's stock rose 18.6% after reporting Q1 adjusted earnings per share of $0.33, exceeding market expectations [5]

Group 1 - Rumors circulated about Jack Ma's return to Alibaba, but he stated he had not heard of such plans [1] - Alibaba CEO Wu Yongming emphasized the need for the company to return to its entrepreneurial roots and embrace innovation in the face of AI technology [2][3] - Alibaba has reportedly reconnected internal network permissions across various business units, allowing employees to collaborate more effectively [3] Group 2 - Tmall's 618 shopping festival will feature a simplified discount model, offering a 15% reduction on purchases, with additional coupons and discounts available [4] - Douyin has intensified efforts to combat fraudulent tipping practices in live streaming, recovering over 1,000 accounts in the first quarter [5] - Dazhong Dianping has launched a reporting channel for users to report harassment from merchants related to reviews [6] Group 3 - The e-commerce platform Dewu reported a doubling of annual sales for 6,120 brands, with over 500 million users, primarily targeting the post-95 demographic [7] - Xiangdao Travel announced a C-round financing of over 1.3 billion RMB and plans for an IPO in Hong Kong [8] - Shenzhou Car Rental initiated a "dirty must compensate" service quality month to enhance vehicle cleanliness standards [9] Group 4 - Google Pay's regulatory oversight by the U.S. Consumer Financial Protection Bureau has been revoked, reversing a previous decision [10] - Tencent has launched an open-source video generation tool, enhancing capabilities for creating customized videos [11] - Semiconductor manufacturer SMIC indicated potential downward adjustments in inventory targets from smartphone clients due to market conditions [13] Group 5 - TSMC reported a 48.1% year-on-year increase in sales for April, reaching 349.57 billion NTD [14] - Major U.S. tech companies discussed the need for increased infrastructure investment and reduced regulatory barriers for AI at a congressional hearing [15] - Elon Musk's AI startup xAI is in talks for new funding, with a potential valuation increase from $80 billion to $120 billion [17] Group 6 - New Hope reported a sales volume of 1.596 million pigs in April, with a revenue of 2.278 billion RMB [33] - Fangzheng Securities announced a leadership change with the retirement of its president and the appointment of a new president [34] - Fosun Pharma received FDA approval for clinical trials of its self-developed product aimed at treating androgenetic alopecia [35][36] Group 7 - Shimao Group reported a cumulative contract sales amount of approximately 9.07 billion RMB for the first four months of 2025 [37]

Group 1 - Alibaba's CEO Wu Yongming emphasized the need for the company to return to its entrepreneurial roots and adapt to the opportunities and risks presented by the AI technology revolution [3][4] - Alibaba has reportedly opened up internal network permissions, allowing employees from various business units to reconnect after two years, indicating a potential shift towards a more unified corporate culture [4] - Tmall's 618 shopping festival will feature a simplified discount structure, offering a 15% discount for single-item purchases, with additional coupons and price protection measures in place [4] Group 2 - TikTok's live streaming platform has intensified efforts to combat "emotional disguise" scams, recovering over 1,000 accounts in the first quarter for violating guidelines [5] - Dazhong Dianping has launched a reporting channel for users to report inducements for positive reviews and harassment for negative reviews, with significant numbers of complaints received during the recent holiday [6][7] - The e-commerce platform Dewu reported a doubling of annual sales for 6,120 brands, with a user base exceeding 500 million, primarily targeting the post-95 demographic in China [8] Group 3 - Xiangdao Travel has completed over 1.3 billion RMB in Series C financing and announced plans for an IPO in Hong Kong, focusing on personal and corporate travel services [9] - Shenzhou Car Rental has initiated a "dirty must compensate" service quality month, promising triple compensation for users who find vehicles not meeting cleanliness standards [10] - Google Pay has had its regulatory oversight lifted by the U.S. Consumer Financial Protection Bureau, reversing a previous decision made during the Biden administration [11] Group 4 - TSMC reported a 48.1% year-on-year increase in sales for April, reaching 349.57 billion NTD, with a 22.2% month-on-month growth [15] - Semiconductor foundry SMIC indicated that smartphone clients may lower inventory targets for Q3, facing price pressure in the foundry industry [14] - Ford has withdrawn its annual earnings guidance due to potential significant impacts from tariffs on net profits, despite reporting better-than-expected Q1 results [27] Group 5 - Panasonic Holdings announced plans to cut 10,000 jobs by 2029, representing about 4% of its global workforce of approximately 228,000 [32] - New Hope reported a sales volume of 1.596 million pigs in April, with a revenue of 2.278 billion RMB, reflecting a year-on-year decrease in revenue [34] - Shimao Group's contract sales for the first four months of 2025 reached approximately 9.07 billion RMB, with an average sales price of 12,209 RMB per square meter [37]

Core Insights - A-share companies reported stable growth in 2024, with total revenue reaching 71.92 trillion yuan and net profit at 5.21 trillion yuan, with 75% of companies profitable and 48% showing year-on-year profit growth [1] Group 1: Industry Performance - The agriculture, forestry, animal husbandry, and fishery sectors saw significant profit growth, with a net profit increase of 1447%, primarily due to falling feed prices benefiting livestock companies [1] - The electronic and non-bank financial sectors led revenue growth, each with approximately 17% increase [1] Group 2: Company Highlights - 117 companies achieved revenue exceeding 100 billion yuan, marking a historical high, with 7 companies surpassing 1 trillion yuan in revenue [1] - BYD's revenue reached 777.1 billion yuan in 2024, a 29% increase, surpassing Tesla's annual revenue for the first time [2] - 65 companies doubled their revenue in 2024, with Zhixiang Jintai leading at a 2384.1% increase due to a newly approved drug [3] Group 3: Profitability - 77 companies reported net profits exceeding 10 billion yuan, with 10 companies surpassing 100 billion yuan, mainly in the banking and insurance sectors [6] - Zhengdan Co. achieved a net profit growth rate of nearly 120 times, driven by soaring prices of its main product [6][7] Group 4: R&D Investment - A-share companies collectively invested 1.6 trillion yuan in R&D in 2024, with 22 companies exceeding 10 billion yuan in R&D spending [8] - BYD led R&D investment with 54.16 billion yuan, contributing to significant technological advancements [8]

Core Viewpoint - The company is a comprehensive pharmaceutical research and development enterprise focused on technology development, providing various services including CRO, technology transfer, and CDMO to over 500 clients in the pharmaceutical industry [5][10]. Company Overview - The company specializes in contract research organization (CRO) services, technology transfer, and custom development and manufacturing organization (CDMO) services, catering to pharmaceutical companies and R&D investment firms [5][10]. - The company has provided over 800 pharmaceutical research and clinical trial services to more than 500 domestic clients [5]. Business Segments - **CRO Services**: The company offers a range of services including raw material synthesis, formulation research, quality research, and stability studies [6][8]. - **Clinical Trials**: The company assists in developing clinical trial protocols, monitoring trial processes, and managing data analysis [8]. - **Registration Services**: The company provides registration application services that comply with both domestic and international requirements, including ANDA and NDA submissions [9]. - **Technology Transfer**: The company engages in technology transfer for certain drug varieties, allowing clients to continue development based on initial results [10]. - **CDMO Services**: The CDMO business, primarily executed by a subsidiary, focuses on process development, optimization, and custom production for generic and innovative drugs [11]. - **Innovative Drug Development**: The company is committed to developing revolutionary drugs targeting major diseases, utilizing AI-driven platforms for drug discovery [12][13]. - **Contracted Innovative Drug Development**: The company enhances its capabilities in contracted R&D and provides comprehensive support to clients throughout the drug development process [14]. Financial Data - The company does not require retrospective adjustments or restatements of previous financial data [15]. - There are no significant discrepancies between the reported financial indicators and previously disclosed quarterly or semi-annual reports [15]. Shareholder Information - The report includes details on ordinary and preferred shareholders, with no preferred shareholders reported during the period [16]. - The company does not have any arrangements for differential voting rights [16]. Important Matters - There are no applicable bond situations as of the report approval date [17].

Group 1: Gold Market Insights - Gold prices have surged to $3,500 per ounce, with predictions from Goldman Sachs raising the 2025 year-end forecast from $3,300 to $3,700 per ounce, and a potential target of $4,500 under bullish scenarios [1] - UBS has also increased its gold price forecast to $3,500, highlighting strong purchasing potential from both institutional and retail investors in China, indicating a release of pent-up demand [1] - The options market has seen extreme volatility, with some contracts experiencing maximum increases of up to 9,800% [3][4] Group 2: Huawei AI Chip Developments - Huawei plans to begin large-scale shipments of its advanced 910C AI chip to Chinese customers as early as next month, with some shipments already initiated [5] - The 910C chip offers double the computing power and memory capacity of its predecessor, the 910B, and is comparable in performance to NVIDIA's H100 chip [5] Group 3: A-Share Market Performance - The A-share market showed mixed results, with the Shanghai Composite Index closing up 0.25% but failing to reclaim the 3,300-point mark, while the Shenzhen Component and ChiNext Index fell by 0.36% and 0.82%, respectively [7] - The market saw a total turnover of 11,213 billion yuan, with over 2,500 stocks rising and 93 stocks hitting the daily limit up [7] Group 4: Plastic Industry Challenges - Chinese plastic factories reliant on imported ethane from the U.S. face significant production risks due to high tariffs, leading to potential shutdowns if they cannot secure alternative raw materials [9][10] - The current tariff of 125% results in a loss of $184 per ton for Chinese factories processing U.S. ethane, compared to a potential profit of over $100 per ton without tariffs [10] Group 5: Sector Performance and Trends - The retail, construction materials, and transportation sectors are leading in performance, while media, communication, and computer sectors are lagging [22] - The trading heat in sectors like oil and gas, retail, and electronics is increasing, while non-bank financials, agriculture, and light manufacturing are at historical low PE ratios [22]